issues

July/August 2009

Download PDF

TABLE OF CONTENTS

David Versus Goliath: Why the Little Guys Have All the Advantages
Derek G. Hennecke, MBA, continues with part 4 of this 6-part series covering unique strategies for building lasting competitive advantages. 

Oral Delivery With Novel Solid Dispersions: Stable Self-Assembled Formulations of Lipophilic Drugs With Improved Bioperformance
Galia Temtsin Krayz, PhD; Maryana Averbuch, PhD; Anna Berman, MSc; Amir Zalcenstein, PhD, MBA; and Irene Jaffe, PhD; review a unique solid dispersion technology for significantly improving the bioperformance of poorly soluble drugs.

Penetrating the Market With Innovative Active Transdermal Technologies
Contributor Cindy H. Dubin discovers that transdermal delivery developers are making their devices more user-friendly and safer by incorporating innovative technology and delivery methods.

Up, Down, Sideways – A Look at Drug Delivery Strategy
Josef Bossart, PhD, believes it is a good time to take a look at how the Specialty Pharma model has played out for companies that decided to take this strategic direction, and how it’s worked out for companies that stayed on the traditional Drug Delivery track.

Medication Management in the Elderly: Major Opportunity for Advances in Drug Delivery & Formulation Technologies
Thomas M. Reilly, PhD, MBA, indicates the development of effective solutions for medication management problems in the elderly represents major market opportunities for drug development companies.

Henkel: Providing Advanced Adhesive Solutions for Drug Delivery Systems
Drug Delivery Executive: Michael Trisch, Global Business Director of Henkel’s Transdermal Business, discusses Henkel’s unique products, innovations, and business strategy.

Pharmaceutical & Biotechnology Outsourcing ““ Growth Opportunities, Trends & Strategies
Frost & Sullivan Analyst Barath Shankar Subramanian says long-term growth fundamentals remain strong for the CRO and CMO markets, which are experiencing two-tiered growth from Big Pharma looking to lower fixed costs, while biotechnology and specialty pharmaceutical companies outsource work due to the lack of infrastructure.

Neurologix: Targeted Gene Therapies for Brain & CNS Diseases
Executive Summary: CEO John Mordock speaks of the opportunities and challenges presented by gene transfer technologies and why gene therapy offers unique benefits as a strategy for improving the treatment of chronic brain disorders.

DEPARTMENTS

Market News & Trends

Excipient Update
Applications of Complementary Polymers in HPMC Hydrophilic Extended Release Matrices

Advanced Delivery Devices
A Proactive Approach to Developing the Cartridge Pump System (CPS) in a Pressurized Market Environment

Technology Showcase

External Delivery
Part Time Productivity: Your Boss Does Notice!

Download Issue

COVER

FEATURES